Thursday, July 10, 2025

Microsoft announces collaboration with NVIDIA to accelerate healthcare and life sciences innovation with advanced cloud, AI and accelerated computing capabilities

Related stories

Warmwind OS: Is It the Next-Generation Platform for Edge and IoT?

Edge operating systems are now important in the realm...

ClickUp Launches Brain MAX, the App Built to End AI Sprawl and Transform

ClickUp, the leading all-in-one productivity platform, announced the launch...

Rackspace Technology announced the launch of Rackspace OpenStack Business

Rackspace Technology, a leading provider of end-to-end hybrid cloud...

Coralogix Partners with AWS to Advance AI Observability and Security

Coralogix, a leading full-stack observability platform, announced a Strategic...

Allyant Announces the Launch of its AI-Powered PDF Remediation Software

Allyant, the leader in accessible document, digital and print...
spot_imgspot_img

Microsoft Corp. is expanding its collaboration with NVIDIA to bring the power of generative AI, the cloud and accelerated computing to healthcare and life sciences organizations. The collaboration will bring together the global scale, security and advanced computing capabilities of Microsoft Azure with NVIDIA DGX Cloud and the NVIDIA Clara suite of computing platforms, software and services to help healthcare and life sciences organizations accelerate innovation and improve patient care. Harnessing the immense power of the cloud, cutting-edge AI and advanced computing capabilities, the collaboration aims to accelerate clinical research and drug discovery, enhance medical image-based diagnostic technology, and increase access to precision medicine.

“Microsoft is building on its longstanding collaboration with NVIDIA to empower the healthcare and life sciences industry with the power of Azure and generative AI, helping unlock new horizons for clinical research, drug discovery and patient care worldwide,” said Peter Durlach, corporate vice president, Health & Life Sciences, Microsoft. “Through this collaboration, we aim to help the industry unlock breakthroughs in healthcare, making care more precise, accessible and effective to deliver a meaningful difference in the lives of patients globally.”

Also Read: RSM & Merit Announce Strategic Alliance: RSM delivers a complete Microsoft Dynamics 365 solution for Life Science Manufacturers with strategic alliance

“The convergence of AI, cloud computing and healthcare is set to transform patient care,” said Kimberly Powell, vice president of healthcare, NVIDIA. “Our collaboration with Microsoft will help unlock new possibilities and drive meaningful impact for patients worldwide.”

The expanded collaboration will extend opportunities for healthcare providers, pharmaceutical and biotechnology companies, and medical device developers to innovate rapidly across clinical research, drug discovery and care delivery with improved efficiency and effectiveness.

Faster drug discovery with NVIDIA BioNeMo on NVIDIA DGX Cloud, hosted on Microsoft Azure

Hosted on NVIDIA DGX Cloud on Azure, NVIDIA BioNeMo offers the quickest path to AI model development and deployment, accelerating the journey to AI-powered drug discovery. BioNeMo is a generative AI platform for drug discovery that simplifies and accelerates the training of models on proprietary data and scales the deployment of models for drug discovery applications. By analyzing vast datasets with unprecedented speed and precision, it can help scientists identify potential drug candidates more efficiently. The implications are profound: faster access to lifesaving therapies for patients worldwide.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img